A First-in-human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UCB3101 in Healthy Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
The purpose of the study is to evaluate the safety and tolerability of a single ascending dose of UCB3101 in cohorts of healthy male and female study participants.
Epistemonikos ID: 5c03c1f0eccfcd3303d340690c1e692b95c82e97
First added on: Apr 17, 2025